About DBI
Company History & Milestones
2025
Current Focus Areas
- Focus on DBI-CorBreath – a new solution for chronic disease monitoring; Extension of DBI’s Breath Metabolome contract research
2024
Strategic Pivot and Breakthrough
- Strategic pivot; IVDR certification of the DBI
-BreathCollector; successful proof-of-concept study in decentralized chronic disease monitoring at USZ
2023
DBI-BreathCollector
- Development start of the DBI-BreathCollector; collaboration with AstraZeneca
2022
First IVD-Certified Product Launch
- Launched DBI-Epibreath — first IVD-certified Therapeutic Drug Monitoring (TDM) software for epilepsy and valproate therapy; collaboration with Bayer
2021
Launch of DBI-Research App and Strategic Collaborations
- DBI-Research app goes live for research collaborations, clinical studies, and breath database development; collaborations with GSK and Löwenstein
2020
Core Team Formation and Rebranding
- Established core team and rebranded to Deep Breath Intelligence AG
2019
Initial Partnerships and Platform Launch
- Provided two SESI-HRMS platforms to partner with UKBB and USZ
2018
Founding and Early Identity
- Founded in 2018 as Deep Breath Initiative AG
Deep Breath Intelligence (DBI) is a Swiss MedTech company using breath analysis and AI/ML for personalized health insights.
© All rights reserved, Deep Breath Intelligence - DBI, 2025. Website Design by 